MOLECULAR IMAGING MARKET ANALYSIS

Market News

• On June 20, 2023, Motilent, a medical technology company, and Minerva Imaging, a biotechnology company, announced a strategic partnership to rethink how to conduct translational research in the study of digestive diseases. Minerva Imaging specializes in innovative techniques like MRI, PET, and nuclear medicine in a variety of preclinical models. Motilent is an expert in quantitative evaluation of the gastrointestinal tract, including problems of the stomach and colon, Crohn's and colitis, and irritable bowel syndrome.
• On February 4, 2023, FUJIFILM India Private Limited, a manufacturer of imaging products, launched the Prime open MRI device APERTO Lucent and two new models in the diagnostic ultrasound range, the Arietta 850 DeepInsight, and Arietta 650 DeepInsight along with its iconic one bone density scanner, the FDX Visionary-DR
• In November 2022, Koninklijke Philips N.V., a multinational conglomerate corporation, announced the global launch of a next-generation compact portable ultrasound solution at the Radiological Society of North America (RSNA) annual meeting held between November 27 and December 1, 2022, in Chicago, U.S. The new Compact 5000 Series from Koninklijke Philips N.V. seeks to make high-end cart-based ultrasound devices' diagnostic capabilities accessible to more people. The Compact 5000 series makes it easier for more patients to have their ultrasound exams done correctly the first time around because of its portability and versatility without sacrificing image quality or performance.
• In July 2022, Life Molecular Imaging, a pharmaceutical company, and BIOKOSMOS, a radiopharmaceuticals company, announced that they had entered into a strategic partnership and licensing agreement providing BIOKOSMOS with rights to manufacture and distribute Neuraceq, an approved imaging agent for the detection of beta-amyloid plaques, in Greece, Bulgaria, North Macedonia, and Albania. Neuraceq is used for the detection of beta-amyloid plaques in the brain and is used in clinical routines. It is also a powerful imaging biomarker for the appropriate characterization of subjects enrolled in clinical trials to support drug development in neurodegenerative diseases.
• In May 2021, Turner Imaging Systems, a developer of advanced X-ray imaging systems, announced that the company had received its CE (European conformity) mark for its Smart-C Mini C-Arm portable fluoroscopy x-ray imaging device. This will make it possible to distribute the Smart-C, the first highly portable micro c-arm in the EU in addition to the UK. In the U.S., the Smart-C is being deployed in hospitals, ambulatory surgical centers, orthopedic clinics, and professional and collegiate sports teams.
• In September 2020,  Akumin Inc. a Diagnostic imaging centers company, and Alliance HealthCare Services, a healthcare service provider, acquired four PET/CET imaging centers in Maryland, Pennsylvania, Alabama and Louisiana.